Mumbai, 10th September2020: SIRO Clinpharm Private Limited, India’s earliest clinical research organization partners with Azidus, a full-service clinical research organization, to strategically expand combined services offerings and avail access to an expanded client base for technical requisites of pharmaceutical and biotechnology industries.
SIRO focuses on patient studies and support trials from Phase II to Phase IV, while Azidus is focused on healthy volunteer studies, bringing synergies to the collaboration. This partnership will help SIRO to expand its product range and get exclusive access to a larger pool of clients in potential geographies of Asia and Latin America, where Azidus has a strong base.
Commenting on the partnership, Akshay Daftary, Director in SIRO Clinpharm and in-charge of Global Business Development Activities and Client Management said, “The synergies of the service offerings of SIRO with Azidus are driven by a common belief in quality; the strategic alliance will serve a strong growth driver for both organizations. This is a complementary alliance which will give the clients single-window end-to-end solutions, with accrued cost benefits. This collaboration resonates strongly with the project growth initiative that we follow as SIRO’s vision. The alliance would definitely boost SIRO’s presence across geographies like Brazil in Latin America and the USA.”
Arjun Arumugam Olaganathan, Director, Azidus, said, “This strategic partnership with SIRO will help both organizations grow and expand their offerings. I see the potential of deeper market penetration and wider service contribution for the two organizations positively affecting their market values through this partnership. Both companies come with deep experience and a vision for excellence, which will also drive better service experience for clients”.
About SIRO Clinpharm:
Incorporated in 1996, SIRO Clinpharm Private Limited is a Clinical Research Organization supporting trials from Phase II to Phase IV and beyond post-launch of products. SIRO offers a range of services, from clinical operations to data services, data analytics and medical writing in compliance with international standards.SIRO has been an industry pioneer over two decades, sharing an incontestable record of excellence in the pharmaceutical, FMCG and medical device industry. Its global delivery centre in Thane has a seasoned team of more than 200 professionals hailing from science and medical backgrounds.
SIRO Clinpharm was founded by Dr. Gautam Daftary in the year 1996, who has over 40+ years of experience in pharmaceutical industry. He currently serves as the Chairman of the organization.
SIRO is currently being managed by Akshay and Karan Daftary.
About AZIDUS:
Azidus laboratories Ltd., India's leading Clinical research organisation, provides comprehensive offerings in BA/BE studies, Bioanalytical services, Clinical trial management, Diagnostic laboratory service, Medical writing, Clinical data management, statistics & Quality assurance. State-of the art Infrastructure
with 480 Bed & 13 ICU bed Clinical facility and bio-analytical facility with 30 LC-MS/MS and 3 ICPMS under one roof.
Azidus is headquartered in Chennai, India and expanded its International presence with Clinical & Bioanalytical site in North America (USA) & Latin America (Brazil) along with strong team of 300+ professionals. Some of the Major health regulators, such as USFDA, EMA, WHO, ANVISA, DCGI, CAP, NABL, MoH Turkey, ISP Chile and others have successfully inspected/approved Azidus.
Azidus Laboratories was founded by Mr. Olaganathan Arumugam in the year 2006, who has over three decades of experience in pharmaceutical industry.
Azidus is currently being managed by a physician, Dr. Arjun Arumugam Olaganathan, MBBS, MD Pharmacology.
Currently Azidus, India is a team comprised of 200 staff members and it has dedicated QA/QC team, Clinical research & medical affairs team, Bioanalytical team, PK & Statistical team.
No comments:
Post a Comment